Select Page

Diabetes

Experiment    –    Understand    –    Teach    –     Improve

Use our glycemic simulator

Using the latest evidence our technology team lead by our Medical Director (Dr D Miller) has created a glycemic simulator that you can use to experiment, learn and teach.

R

Select a patient

Select one of the many different types of patients in the glycemic simulator

R

Try an intervention or drug

And see how it affects the patient’s A1C, FBG and 48hr insulin values

R

Experiment and Learn

As you learn your skills and understanding will improve. Experiment and keep trying various interventions until you succeed in controlling the patient’s A1C

Go To Our Simulated Patients and Start Learning

Go To Simulator

Number of Drugs in Simulator

Simulated Patients

Physicians who have used the simulator

Number of simulations run

Using a new technique that is realistic and visual

Increase Understanding

Understand the physiology of the disease and how various interventions – including lifestyle and pharmakinetics – impact long and short term life outcomes.

Increase Confidence

Through a better understanding of how insulin works within the body and how interventions can affect long and short term impacts on people’s lives, learners will become much more confident in their ability to manage the disease.

Improve Outcomes

Through better understanding of the disease and greater confidence in day-to-day management, long and short term outcomes will improve.

Decrease Medical Costs

Greater confidence and improved outcomes result in fewer Emergency Rooms visits and a better quality of life for patients.

Go to Simulated Patients

Go To Simulation
  • Likelihood of specialist medication intensification if A1C >8* 45%
  • Likelihood of GP medication intensification if A1C >8* 37%
  • Specialist insulin starts* 8.5%
  • GP insulin starts* 1.7%

Time Per Simulation (min)

%

Physiciancs strongly agree the simulations are realistc

*Clinical inertia in response to inadequate glycemic control – Diabetes Care 28:600-606, 2005

Core Features

Physiological Simulator

We have developed a simulated engine that mimics the production of glucose and insulin within the human body. In addition to this we have added the phenomena of dynamic insulin resistance and combined this with carbohydrate absorption factors which has given us the ability to reproduce any type of diabetic patient profile.

Drug Simulator

We have also created algorithms that mimic the pharmacodynamic effects of the most commonly used diabetic drugs. You can gain complete confidence by interacting with our realistic simulation algorithm engine which contains over 29 of the most commonly used drugs in North America. Simation Medical has mathematically modeled basal and bolus insulin as well as non-insulins such as the older sulfonylureas and newer GLP agents. You can learn how to use the latest class of DPP4 and GLP agents in complete confidence.

Gamification Module

On top of the foundation simulators we have built a gamification platform that can be adapted to provide a variety of different learning and evaluation experiences. The gamification elements can be used to instruct and evaluate users in a variety of different ways from time and frequency of administration to interactions as well as correct dosing per condition.  We can apply virtual patient responses and effects other simulated interventions such as diabetes education.

About Simation

Simation develops complex predictive algorithmic branching simulations that have motivated thousands of professionals to challenge their working paradigms. Our experienced team has produced some ground-breaking CME programs that have received Main-ProC accreditation by the College of Family Physicians of Canada and the PRA Category 1 Credit from the American Medical Association.

Why We Built the Simulator

Diabetes is a complex disease that has been historically treated by specialists and as the pandemic increases the burden of care is switching to primary care professionals. Our objective is to de-mystify the nuances of managing this disease by reducing the apprehension of hypoglycemia inducement and increase the preparedness and capacity by increasing the familiarity with insulin, and other diabetic medication regimens.

Simulation Pedigree

Simation has produced a number of training simulations which were given the highest accreditation possible by the College of Family Physicians of Canada. We have been adding to these patient cases over the past 3 years and with the help of prominent endocrinologists and other medical professionals we have refined the simulated outcomes.

Dr Miller

Dr. Miller has been a consultant endocrinologist in Victoria, British Columbia and with the Vancouver Island Health Authority since 1997. He is Head of the Section of Endocrinology and has clinical faculty appointments at the University of British Columbia and the University of Victoria. Dr. Miller’s publications have included the Journal of Clinical Endocrinology and Metabolism, the Archives of Internal Medicine, and the Canadian Journal of Diabetes, amongst others.

See how SimulusDM can help you

Go To Simulation

Ethical Disclosure

There has been no funding provided, or involvement with, the pharmaceutical industry in any regard during the development of the Glycemic Simulator program. Dr. Miller is the medical subject matter expert for the Simulator and as such will be appropriately compensated for his expertise and time. In the past 5 years Dr Miller has been a clinical investigator in multi-center clinical trials for Eli-Lilly and Novo-Nordisk.  He has received speaker’s honoraria from Eli-Lilly, Novo-Nordisk and Sanofi-Aventis.  He does not sit on any advisory boards nor owns stock in any of the aforementioned companies.